Why in the world do we need a nanomaterials description system – How CODATA and VAMAS answers that question
12 Mar 2015 | Presentations | Contributor(s): John Rumble
Nano WG March12, 2015
So What Can We Do With Nano Informatics? – Leveraging Decision Analytic Tools
22 Jan 2015 | Presentations | Contributor(s): Igor Linkov, Matthew Bates
Jan 22, 2015 meeting Nanotechnology Working Group Matthew E. Bates & Igor Linkov Risk & Decision Science Team Environmental Laboratory, Engineer Research and Development Center, US Army...
Video: Learn how TIES can help manage research resources
16 Jan 2015 | Presentations | Contributor(s): Girish Chavan, Rebecca Crowley
Some Thoughts on Reproducibility
05 Dec 2014 | Presentations | Contributor(s): John Rumble
Nano WG December 4, 2014
Data, Metadata and "Data Quality" for Databases
05 Dec 2014 | Presentations | Contributor(s): Frederick C. Klaessig, Mervi Heiskanen
Nano WG December 4, 2014
Data ReproducibilityNanotechnology Knowledge Infrastructure Data Curation
05 Dec 2014 | Presentations | Contributor(s): Martin Fritts
Nano WG presentation on December 4, 2014
CRAVAT Introduction Video - Cancer Related Analysis of Variants
03 Dec 2014 | Teaching Materials | Contributor(s): Michael C Ryan
This video provides a brief overview of the CRAVAT web service(http://www.cravat.us/). CRAVAT provides annotation and analysis of cancer mutations. CRAVAT is free, very easy to use, and can handle large volumes of mutations.[[Youtube(xovmIy11Bcs)]]Please switch to 1080 resolution and watch...
LBL ICBP50 integrative genomic data
13 Nov 2014 | Downloads | Contributor(s): Joe Gray, Jonathan Bistline
From Joe Gray, Lawrence Berkeley National Laboratory. There are seventeen (17) files in this study: Affymetrix U133A gene expression data (icbp_u133a.gct) Affymetrix U133A gene expression data (ICBP_U133a.zip) Affymetrix splice junction exon-exon data (ICBP_Junction.zip) Affymetrix...
Baylor Residual breast cancer
13 Nov 2014 | Downloads | Contributor(s): Creighton C, Lewis M, Chang J, Jonathan Bistline
Residual breast cancers after conventional therapy display mesenchymal as tumor-initiating features. There are four (4) files included in this study: Sample Annotation (combined_sample_annotation.txt) Gene expression data from CD44+/CD24- cells sorted by flow cytometry (GSE7513.gct) Human...
Summarization of Big Data
07 Nov 2014 | Presentations | Contributor(s): Jeffrey A. Blimes
All about assay selection...
Integrated analysis of breast cancer cell lines reveals unique signaling pathways
16 Sep 2014 | Publications | Contributor(s): Laura M Heiser, Nicholas J Wang, Carolyn L Talcott, Keith R Laderoute, Merrill Knapp, Yinghui Guan, Zhi Hu, Safiyyah Ziyad, Barbara L Weber, Sylvie Laquerre, Jeffrey R Jackson, Richard F Wooster, Wen Lin Kuo, Joe W Gray, Paul T Spellman
AbstractBackgroundCancer is a heterogeneous disease resulting from the accumulation of genetic defects that negatively impact control of cell division, motility, adhesion and apoptosis. Deregulation in signaling along the EgfR-MAPK pathway is common in breast cancer, though the manner in which...
An ISA-TAB Nano compliant data management system for nanosafety modelling
10 Sep 2014 | Presentations | Contributor(s): Robert Rallo
Dr. Robert RalloAssociate Professor , Universitat Rovira i Virgili, Departament d'Enginyeria Informàtica i MatemàtiquesTarragona, SpainNano WG presentation July 10, 2014[[Image(<Capture.PNG>)]]
Design and Applications of the CEINT Database
10 Sep 2014 | Presentations | Contributor(s): Sandra Karcher, Yuan Tian
Nano WG presentation September 4, 2014Post-doctoral research associates Dr. Sandra Karcher and Dr. Yuan Tian, Duke University
caNanoLab: data sharing to expedite the use of nanotechnology in biomedicine
13 Dec 2013 | Publications | Contributor(s): Sharon Gaheen, George W Hinkal, Stephanie A Morris, Michal Lijowski, Mervi Heiskanen, Juli Klemm
The use of nanotechnology in biomedicine involves the engineering of nanomaterials to act as therapeutic carriers, targeting agents and diagnostic imaging devices. The application of nanotechnology in cancer aims to transform early detection, targeted therapeutics and cancer prevention and...